MK-7602
N/A
Report date: 2024/04/07 18:02:45
NME
Base Information
Drug NameMK-7602
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme LLCWalter And Eliza Hall Institute Of Medical Research
China Registration ClassN/A
Develop Information
Active CompaniesMerck Sharp & Dohme LLC
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A